Population pharmacokinetic analysis of mycophenolic acid in renal transplant recipients following oral administration of mycophenolate mofetil.
about
Nonlinear relationship between enteric-coated mycophenolate sodium dose and mycophenolic acid exposure in Han kidney transplantation recipientsPopulation pharmacokinetics and Bayesian estimator of mycophenolic acid in children with idiopathic nephrotic syndrome.Population pharmacokinetics of mycophenolic acid and metabolites in patients with glomerulonephritis.Population pharmacokinetics of mycophenolic acid in children and young people undergoing blood or marrow and solid organ transplantationNonlinear relationship between mycophenolate mofetil dose and mycophenolic acid exposure: implications for therapeutic drug monitoringCharacterizing the role of enterohepatic recycling in the interactions between mycophenolate mofetil and calcineurin inhibitors in renal transplant patients by pharmacokinetic modelling.Mycophenolic acid pharmacokinetics and related outcomes early after renal transplantTime-dependent clearance of mycophenolic acid in renal transplant recipientsDevelopment of population PK model with enterohepatic circulation for mycophenolic acid in patients with childhood-onset systemic lupus erythematosus.Individualization of mycophenolate mofetil dose in renal transplant recipients.Mycophenolate mofetil in organ transplantation: focus on metabolism, safety and tolerability.Population pharmacokinetics and dose optimization of mycophenolic acid in HCT recipients receiving oral mycophenolate mofetil.Pharmacokinetics, Pharmacodynamics, and Pharmacogenomics of Immunosuppressants in Allogeneic Hematopoietic Cell Transplantation: Part II.The evolution of population pharmacokinetic models to describe the enterohepatic recycling of mycophenolic acid in solid organ transplantation and autoimmune diseasePharmacokinetic evaluation of mycophenolate mofetil for pemphigus.Clinical pharmacokinetics and pharmacodynamics of mycophenolate in patients with autoimmune disease.How accurate and precise are limited sampling strategies in estimating exposure to mycophenolic acid in people with autoimmune disease?Clinical mycophenolic acid monitoring in liver transplant recipients.Population pharmacokinetics and Bayesian estimation of mycophenolic acid concentrations in Chinese adult renal transplant recipients.Population pharmacokinetics of mycophenolic acid and its glucuronide metabolite in lung transplant recipients with and without cystic fibrosis.Bayesian estimation of mycophenolate mofetil in lung transplantation, using a population pharmacokinetic model developed in kidney and lung transplant recipients.Mechanism-based enterohepatic circulation model of mycophenolic acid and its glucuronide metabolite: assessment of impact of cyclosporine dose in Asian renal transplant patients.Population pharmacokinetics of mycophenolic acid and its 2 glucuronidated metabolites in kidney transplant recipients.Mycophenolic Acid and Its Metabolites in Kidney Transplant Recipients: A Semimechanistic Enterohepatic Circulation Model to Improve Estimating Exposure.
P2860
Q33683136-CC817086-63C0-4051-9F5B-BDE76C0BE0E4Q33764995-26BF496E-4103-4A5A-8207-EC83D2B73774Q34152549-253C067F-D3ED-4A42-ACBF-4308218FAA3FQ34180482-EB52D8D3-4D20-4BFD-9069-DF47BDF64243Q34858098-8D7BA117-A74F-44CF-8D05-7111AEE9592CQ35826755-58F7F506-5EAB-47DA-9058-89E867BE68C6Q35826828-BDC6B812-5F1F-41A8-94FC-AF83D81E769FQ36024478-867FFBDF-8487-4CD9-8ED2-8FF18C7B1D43Q36111207-6BE9EC53-4293-4443-A4AF-9F2A26E3B215Q36407345-53B0ABA8-853C-49D4-B596-507BD0CF319BQ36544988-DB8F8607-0DE1-427D-9839-A9F08BAFDF7BQ36728151-ED4DC604-8EA7-493F-B533-A7A1764239EFQ36777485-B72C9A2F-E2B6-43BC-AF82-C24EE3E7E0D1Q37818144-985EAC47-C084-4347-924A-573C598023F7Q37824708-A354F6B9-A65E-4A5B-922F-1443A6E979D1Q38087925-5A6A7784-A34B-443F-8626-289C4E0B18F8Q38170321-7B2E3EAE-C827-41E0-8964-A0E160CFBE87Q38242804-923E7AD5-00C1-4449-8DE5-C14DC28A9E2CQ38610665-726D5246-EF5A-4205-9E26-8506F1D358FEQ39338374-FA2A5F53-98F9-4301-8344-5F4C753C4135Q43921775-EABCC502-0D94-4AAC-9D16-A473A82B8E18Q46040442-4663D065-CCC0-48A0-8A79-D1744EE0FC15Q46140802-FADF61BE-E626-4B15-9297-6A4E54E64144Q48252498-0237876E-E06B-477C-AFD0-151B871FF8F3
P2860
Population pharmacokinetic analysis of mycophenolic acid in renal transplant recipients following oral administration of mycophenolate mofetil.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Population pharmacokinetic ana ...... tion of mycophenolate mofetil.
@ast
Population pharmacokinetic ana ...... tion of mycophenolate mofetil.
@en
type
label
Population pharmacokinetic ana ...... tion of mycophenolate mofetil.
@ast
Population pharmacokinetic ana ...... tion of mycophenolate mofetil.
@en
prefLabel
Population pharmacokinetic ana ...... tion of mycophenolate mofetil.
@ast
Population pharmacokinetic ana ...... tion of mycophenolate mofetil.
@en
P2093
P2860
P1476
Population pharmacokinetic ana ...... tion of mycophenolate mofetil.
@en
P2093
P2860
P304
P356
10.1046/J.1365-2125.2003.01863.X
P407
P577
2003-08-01T00:00:00Z